2nd Quarter 2023
Plastic Surgery Market Update
Capital Advisors
- Middle-market healthcare M&A deal volume has declined 15% quarter over quarter while median deal valuation rose over 20%
- Ongoing economic uncertainty and rising cost of capital has caused up-market buyers to pursue smaller add-ons for current platforms as large platform investments become less attractive
- Healthcare Services deal volume has remained resilient through Q2 (47% of Healthcare M&A volume) despite economic headwinds
- For outpatient/alternate site services, ACA has seen retail and patient payment models becoming more attractive as buyers seek to mitigate fee-for-service risks
- Buy-and-build volume remains strong, specifically within the physician services segment (orthopedics, plastic surgery, women's health, etc.), as several large platforms are expected to transact in 4Q 2023 – 1Q 2024
- ACA remains optimistic about the Healthcare M&A outlook given financial buyers are still sitting on large amounts of capital to be deployed and competition for attractive deals moves further down the market
Allow us to introduce ourselves
Contact us today and we will be happy to provide more information about Addicus and schedule an introductory meeting.